PETS PetMed Express Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against PetMed Express, Inc.

NEW YORK--(BUSINESS WIRE)--

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PetMed Express, Inc. (NASDAQ: PETS) resulting from allegations that PetMed may have issued materially misleading business information to the investing public.

On August 23, 2017, Aurelius Value published an article alleging that PetMed targets opioid users with Google ads and other marketing techniques aimed at facilitating the abuse of opioids. On this news, shares of PetMed fell $3.19 per share or over 8% to close at $36.22 per share on August 23, 2017, damaging investors.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by PetMed investors. If you purchased shares of PetMed on or before August 23, 2017, please visit the firm’s website at http://www.rosenlegal.com/cases-1199.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

EN
23/08/2017

Underlying

PETSPetMed Express Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetMed Express Inc.

 PRESS RELEASE
Free
PETS PetMed Express ...

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Pro...

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited No Stockholder Action Required at this Time DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today confirmed that it has received an unsolicited and non-binding acquisition proposal from SilverCape Investments Limited, a Singapore-based investment firm, to acquire all of the outstanding shares of the Company for $4 per share in cash, subject to variou...

December 11, 2025 1 EN
 PRESS RELEASE
Free
PETS PetMed Express ...

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets ...

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds’ giftable assortment focuses on products that improve pets’ everyday health, comfort, safety...

December 10, 2025 1 EN
 PRESS RELEASE
Free
PETS PetMed Express ...

PetMeds Extends Existing Shareholder Rights Plan

PetMeds Extends Existing Shareholder Rights Plan DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced that its Board of Directors (the “Board”) has unanimously approved an amendment to the Company’s existing shareholder rights plan (the “Rights Plan”), pursuant to which the expiration date of the Rights was extended for one year from the close of business on December 2, 2025 until the close of business on December 2, 2026. All other terms and conditions of the Rights Plan ...

November 26, 2025 1 EN
 PRESS RELEASE
Free
PETS PetMed Express ...

PetMed Express, Inc. Announces Preliminary Second Quarter Results and ...

PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq DELRAY BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced preliminary second quarter fiscal year 2026 results and filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Form 10-Q for the quarter ended September 30, 2025 within the prescribed time period...

November 13, 2025 1 EN
 PRESS RELEASE
Free
PETS PetMed Express ...

PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as ...

PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- , d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced the appointment, effective immediately, of James LaCamp to the Company’s Board of Directors (the “Board”), and effective October 30, Mr. LaCamp will become Chair of the Audit Commit...

October 20, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch